|
|
|
14.04.26 - 01:01
|
Stocks Extend Gains on Trump Comments | The Close 4/13/2026 (Bloomberg)
|
|
|
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Wells Fargo Investment Institute's Paul Christopher, KBW CEO Thomas Michaud, Rochefort Co-CEO Kyle Bass, Zoetis CEO Kristin Peck, Bokeh Capital Partners' Kim Forrest, Albright Stonebridge Group's Puneet Talwar, JPMorgan Asset Management's Aaron Mulvihill, Aon CEO Greg Case, & Piper Sandler's Scott Siefers. (Source: Bloomberg)...
|
|
|
13.04.26 - 12:03
|
Medtronic to announce financial results for its fourth quarter and full fiscal year 2026 (PR Newswire)
|
|
|
GALWAY, Ireland, April 13, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Wednesday, June 3, 2026, for its fourth quarter and full fiscal year 2026, which ends on Friday, April 24, 2026. A......
|
|
|
10.04.26 - 22:06
|
Prothena Announces Leadership Team Updates (Business Wire)
|
|
|
DUBLIN--(BUSINESS WIRE)--$PRTA #Prothena--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced updates to its leadership team. Annie Kingston is being promoted to Chief Strategy Officer and Michael Isaacs is being promoted to General Counsel and Corporate Secretary. Mr. Isaacs succeeds Michael Malecek who will be departing from Prothena. Ms. Kingston and Mr. Isaacs will join Prothena's leadership team and will report to Gene Kinney, Ph.D., President and Chief Executive Officer. Ms. Kingston's promotion is effective immediately and Mr. Isaacs' promotion will take effect following Mr. Malecek's departure in June.
Ms. Kingston will lead the Company's growth strategy aimed at driving sustainable value creation and Mr. Isaacs will be the Company's most senior legal officer, overseeing the corporate legal function. Tran Nguyen, who previously served as Chief Finan...
|
|
|
|
|
09.04.26 - 16:18
|
Global Weight Loss and Obesity Management Market | 12.8% CAGR Growth Trajectory | Asia Pacific, North America Lead | Novo Nordisk, Eli Lilly, Medtronic Drive Integrated Care Evolution (PR Newswire)
|
|
|
NEWARK, Del., April 9, 2026 /PRNewswire/ -- According to the latest analysis by Future Market Insights, the global weight loss and obesity management market is undergoing a transformative expansion, fueled by rising obesity prevalence, growing health awareness, and rapid innovation across......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.04.26 - 22:06
|
Inogen Announces the Appointment of Vafa Jamali to Board of Directors (Business Wire)
|
|
|
BEVERLY, Mass.--(BUSINESS WIRE)--$INGN #AirwayClearance--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Vafa Jamali as an independent director to the Inogen Board of Directors (the “Board”), effective on the date of the Company's 2026 Annual Meeting, or June 15th if earlier.
Mr. Jamali is a long-time medical device executive who will bring added depth and expertise to the Board. During his tenure as the Chief Executive Officer of ZimVie, he led the company's Nasdaq listing following the spin-out from Zimmer Biomet and helped each of the businesses (Spine and Dental) through significant portfolio optimization actions to support a turnaround to higher growth and profitability. Prior to ZimVie, most notably, he spent nearly twelve years at Covidien and Medtronic, where he most recently served as Senior Vice President and President of the Respiratory, Gastrointestinal & Informatics div...
|
|
|
|
|
|
|
01.04.26 - 00:12
|
How Ireland became dependent on big pharma — and the risks ahead (CNBC)
|
|
|
In just 50 years, Ireland has become the world's third largest exporter of pharmaceuticals, with medicines now making up about 20% of Ireland's GDP. So how did Ireland become so tied to the pharma industry — and is that reliance at risk amid tariffs, patent cliffs and geopolitical tension?...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
